Introduction
============

There have been few attempts to provide comprehensive, consistent and comparable estimates of the burden of acute foodborne diseases.[@R1] In 2006, however, the World Health Organization (WHO) set up the Foodborne Disease Burden Epidemiology Reference Group (FERG) specifically to produce such estimates.[@R2] FERG aims to provide the data and tools needed to set appropriate, evidence-informed priorities for food safety at country level. Since its launch, FERG has established several task forces that focus on parasitic and enteric diseases, chemicals and natural toxins, source attribution, computational modelling and country studies. The members of the country studies task force were asked to develop methods for estimating the burden posed by foodborne disease at national level. These methods were intended to facilitate the collection of national data on foodborne disease burdens and support the use of such data for policy-making and practice in food safety.[@R3] FERG selected Albania, Japan, Thailand and Uganda as the locations for initial pilot studies estimating disability-adjusted life-years (DALYs) lost as a result of foodborne disease.[@R4]^,^[@R5]

In Japan, priorities for foodborne disease prevention are primarily based on the apparent public health significance of each disease, although impact on the food market, consumers' risk perceptions and public opinion are also taken into consideration.[@R6] The Japanese Food Sanitation Act and Infectious Disease Control Act require collection of data on the incidence of food poisoning and infectious diseases, respectively. However, as there has never been a comprehensive, internally consistent and robust assessment of the burden posed by foodborne disease in Japan, robust and objective standards for ranking priorities are lacking. Surveillance data are not as useful as formal estimates when identifying and ranking diseases in terms of their contributions to the country's overall burden. Our objective is to assess the burden posed by common foodborne diseases in Japan, using the methods recommended by FERG and expressing the main findings in terms of DALYs.

Methods
=======

Disease selection
-----------------

After analysis of food poisoning statistics and consultation with experts, we identified *Campylobacter* species, *Salmonella* species and enterohaemorrhagic *Escherichia coli* (EHEC) as the first, second and third most common causes of foodborne disease in Japan in 2011.[@R7] This ranking was entirely based on clinical cases in health facilities. To estimate the relative burden posed by each of these three causes of foodborne disease, we used a pyramid reconstruction method and supplemented routine surveillance and reporting data with information from telephone and patient surveys.

Data sources
------------

We used data from four sources to estimate the annual incidence of acute gastroenteritis caused by *Campylobacter, Salmonella* and EHEC and to estimate associated mortality rates. The four data sources were: (i) food poisoning statistics that had been compiled using information collected by local governments on outbreaks of food poisoning; (ii) surveillance data on EHEC (routine collection of data on EHEC cases in Japan was not made a legal requirement until 1999; disease caused by *Salmonella* or *Campylobacter* species was not recorded);[@R8]^,^[@R9] (iii) national patient surveys for 1996, 1999, 2002, 2005, 2008 and 2011. (These surveys record patients in hospitals and clinics on a single day in October, coded according to the International Classification of Diseases \[ICD-10\]);[@R10] and (iv) vital registration records assimilated by the Japan Ministry of Health, Labour and Welfare.[@R11]

Incidence estimation
--------------------

Because of the limitations of the reported statistics, the annual numbers of cases of acute gastroenteritis attributable to foodborne disease caused by *Campylobacter* (*Y*~1~), *Salmonella* (*Y*~2~) and EHEC (*Y*~3~) were estimated using the formulae: where 31 represents the number of days in October. *A~i~* represents the corresponding reported incidence -- *A~1~* and *A~2~* estimated from the patient survey data and disease durations[@R12] and *A~3~* derived from the data collected from infectious disease surveillance. *W~i~* represents the proportions of infection attributable to foodborne disease. *B~i~* represents seasonality -- calculated as the number of cases of acute gastroenteritis caused by *Campylobacter* or *Salmonella* on survey days divided by the corresponding daily mean numbers of cases of acute gastroenteritis caused by *Campylobacter* and *Salmonella* recorded in the survey years. *C* represents the proportion of incident cases confirmed by stool examination. *D* represents the proportion of incident cases who visited a physician. Data for the estimation of *C* and *D* were derived from population-based telephone surveys.[@R13]^,^[@R14]

We used a Bayesian method to estimate the probability distributions of *B~i~*, *C* and *D*. We assumed that *C* and *D* followed binomial probability distributions with a beta prior distribution for the binomial probability parameter. Because the beta prior is the conjugate distribution of the binomial likelihood, the posterior distribution is also beta-distributed.[@R15] We assumed a uniform prior distribution -- i.e. a special case of the beta distribution in which the probability parameter lies between 0 and 1.[@R14] Once we had obtained three beta distributions, we assumed that the parameters underlying them were mutually independent and used Mathematica version 8 (Wolfram Research, Hanborough, United Kingdom of Great Britain and Northern Ireland) to calculate the distribution as the product of the three independent distributions.

Finally, the proportions (*W~i~*) of *Y~1~*, *Y~2~* and *Y~3~* attributable to foodborne disease were estimated using an expert elicitation process similar to that done in the Netherlands.[@R16] We invited contributions to this estimation from experts from different scientific backgrounds -- microbiology, epidemiology and food science. We invited 88 experts and thirty (34.1%) agreed to participate. We asked the experts to provide their best estimate of the percentages of individuals with gastroenteritis caused by *Campylobacter*, *Salmonella* or EHEC that had become infected by each of five pathways: food, environment, animal--human, human--human and travel. We also asked the experts to estimate the 90% confidence limits around their best estimates. Individual expert opinions were represented in terms of a Dirichlet distribution. Where more than one expert provided an opinion on the same pathway we combined the estimates using a Bayesian update method with equal weighting (details available from the corresponding author).

Complications
-------------

In our investigation of the burden caused by complications of gastroenteritis, we used outcome trees based on a European study.[@R17] The complications resulting from *Campylobacter* included Guillain-Barré syndrome, inflammatory bowel disease and reactive arthritis; from *Salmonella*, inflammatory bowel disease and reactive arthritis and from EHEC, haemorrhagic colitis and haemolytic-uraemic syndrome.[@R17]^,^[@R18]

We used systematic reviews of prospective cohort studies to estimate the proportions of these complications that could be attributed to gastroenteritis caused by each infectious agent. We searched the Japan medical abstract society database and Embase for relevant articles published between 1 January 1983 and 29 February 2012 and Medline for relevant articles published between 1 January 1946 and 29 February 2012.[@R19] The search terms were designed by an information specialist using the appropriate medical subheadings (available from the corresponding author). We included prospective cohort studies that described, in English or Japanese, the proportions of laboratory-confirmed sequelae that resulted from gastroenteritis caused by *Campylobacter, Salmonella* or EHEC. We only used published data and made no attempt to obtain any further data from the authors of relevant articles. We excluded case reports, review papers, letters, comments, conference proceedings, studies with insufficient information on criteria, studies that only provided aggregated data for multiple conditions and unpublished studies ([Fig. 1](#F1){ref-type="fig"}).
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The title, abstract and, if appropriate, the full text of each eligible article of potential interest were screened by two authors independently. Discrepancies were resolved by discussion and consensus. We collected information on the year of publication, study duration, country and area, data source or sources, follow-up period, sample size, serotype, age group, sex, case definition and the incidence of sequelae and their associated standard errors. We assessed the quality of each included study using the Newcastle-Ottawa scale.[@R20]

Data analysis
-------------

Meta-analyses of the proportions of sequelae attributable to gastroenteritis caused by *Campylobacter, Salmonella* or EHEC were done to generate pooled values of prevalence with 95% uncertainty intervals. Heterogeneity among studies was estimated using Cochran's *Q* and the *I*^2^ statistic. Either the Freeman-Tukey double arcsine transformation or log--normal random-effects were used to stabilize model variances.[@R21]^--^[@R69] Potential sources of heterogeneity were investigated further by analysis of subgroups by age and methods of laboratory confirmation. We used random-effects models[@R70] in Stata version 13 (StataCorp. LP, College Station, United States of America).

Estimation of mortality
-----------------------

Data on gastroenteritis-related deaths caused by *Campylobacter*, *Salmonella* or EHEC *--* (ICD-10 codes A045, A02 and A043 respectively) and sequelae such as Guillain-Barré syndrome, inflammatory bowel disease or haemolytic-uraemic syndrome (ICD-10 codes G610, K50/K51 and D59.3 respectively) were obtained from the Japan vital registration system.[@R11] These mortality estimates were adjusted based on the proportions estimated to be attributable to foodborne disease. We did not adjust for possible misclassification.

Estimation of burden
--------------------

We used DALYs to assess the burden of foodborne disease caused by *Campylobacter*, *Salmonella* or EHEC in Japan in 2011. DALYs combine the years of potential life lost due to premature death with the years lived with disabilities.[@R71] We estimated years of potential life lost by multiplying the number of deaths due to a particular form of foodborne disease by the number of potential life-years lost due to premature death from that disease. The latter was based on standard life expectancies from the Global Burden of Disease (GBD) 2010 study.[@R72] The corresponding years lived with disabilities were calculated as the product of the number of incident cases of a particular form of foodborne disease, the mean duration of that disease and the disability weight for that disease. Age-specific disease incidences were estimated from the age distributions recorded in food poisoning and infectious diseases statistics for Japan. Whenever possible, we used disease durations and disability weights from studies conducted in Europe.[@R17]^,^[@R18] To be consistent with the assumptions made in the GBD 2010 study, we did not apply any discounting or non-uniform age-weighting. DALY components were calculated separately for each sex and age group and then summed to obtain estimates of the total burdens.

Uncertainty analysis
--------------------

Uncertainty intervals were derived by Monte-Carlo simulation within the R statistical package (R Foundation for Statistical Computing, Vienna, Austria). Appropriate probability distributions were specified for parameters that, based on the published literature, were considered to be important sources of uncertainty. Estimates were repeatedly calculated from randomly drawn sets of input values, and 95% uncertainty intervals were derived from the 2.5th and 97.5th percentiles of the output values. The process was continued until the difference between the means of the incremental iterations satisfied the stopping criterion of less than 1 unit difference in the mean of the outcome estimates. The number of draws ranged from 22, for acute gastroenteritis caused by *Campylobacter*, to 52 951, for inflammatory bowel disease caused by *Salmonella*.

Results
=======

Incidences of acute gastroenteritis
-----------------------------------

[Table 1](#T1){ref-type="table"} shows the incidence of gastroenteritis caused by foodborne *Campylobacter*, *Salmonella* or EHEC reported in the routine surveillance data, and the corresponding -- much higher -- adjusted incidences that we estimated using the pyramid reconstruction method. [Fig. 2](#F2){ref-type="fig"} shows the estimated annual incidence of acute gastroenteritis caused by foodborne *Campylobacter*, *Salmonella* or EHEC between 1996 or 1999 and 2011. Over this period, there was no clear trend in the incidence of acute gastroenteritis caused by foodborne *Campylobacter* or EHEC but the incidence of gastroenteritis caused by foodborne *Salmonella* appeared to fall substantially after 2002.

###### Estimated incidences of acute gastroenteritis, Japan, 2011

  Data source                 Causative agent        Estimated no. of cases   Estimated incidence, cases per 100 000 population (95% UI)
  --------------------------- ---------------------- ------------------------ ------------------------------------------------------------
  Food poisoning statistics   *Campylobacter* spp.   2341                     1.8 (1.1--2.8)
  *Salmonella* sp.            3068                   2.4 (1.5--3.6)           
  EHEC                        714                    0.6 (0.2--1.3)           
  Pyramid reconstruction      *Campylobacter* spp.   118 502                  92.5 (55.2--154.5)
  *Salmonella* sp.            40 571                 31.7 (19.2--51.8)        
  EHEC                        103 338                80.7 (49.5--133.1)       

EHEC: enterohaemorrhagic *Escherichia coli*; UI: uncertainty interval.
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Disease burdens
---------------

[Table 2](#T2){ref-type="table"} summarizes the experts' estimates of the proportions of the acute gastroenteritis incidence that can be attributed to foodborne transmission and other pathways. [Table 2](#T2){ref-type="table"} also shows the corresponding Bayesian factors used to adjust for seasonality, physician visits and stool examination -- i.e. the denominators of [Equation 1](#E1){ref-type="disp-formula"}, [Equation 2](#E2){ref-type="disp-formula"} and [Equation 3](#E3){ref-type="disp-formula"}.

###### Estimated proportions of gastroenteritis cases resulting from foodborne transmission and other pathways, Japan, 2011

  Causative agent        No. of experts^a^   Transmission pathway, % (95% UI)   Bayesian adjustment factor (95% UI)                                                        
  ---------------------- ------------------- ---------------------------------- ------------------------------------- ------------------ ---------------- ---------------- -------------------
  *Campylobacter* spp.   15                  82.0 (78.5--85.5)                  8.3 (6.7--10.1)                       3.1 (2.1--4.3)     0.2 (0.0--0.5)   6.4 (5.0--8.0)   0.17 (0.08--0.32)
  *Salmonella* sp.       14                  79.3 (74.7--84.0)                  2.7 (1.7--3.8)                        10.1 (8.4--12.0)   3.4 (2.4--4.7)   4.5 (3.2--5.9)   0.26 (0.12--0.47)
  EHEC                   20                  77.6 (73.4--81.8)                  4.0 (2.8--5.3)                        8.5 (6.9--10.4)    6.0 (4.6--7.6)   3.9 (2.8--5.29   2.23 (0.97--4.00)

EHEC: enterohaemorrhagic *Escherichia coli*; UI: uncertainty interval.

^a^ These experts were asked to estimate the proportions of gastroenteritis cases resulting from each transmission pathway.

[Table 3](#T3){ref-type="table"} shows the results of our systematic review and meta-analysis of the prevalence of various complications that may occur after infection with *Campylobacter*, *Salmonella* or EHEC ([Fig. 3](#F3){ref-type="fig"}, [Fig. 4](#F4){ref-type="fig"}, [Fig. 5](#F5){ref-type="fig"}, [Fig. 6](#F6){ref-type="fig"}, [Fig. 7](#F7){ref-type="fig"}, [Fig. 8](#F8){ref-type="fig"} and [Fig. 9](#F9){ref-type="fig"}; all available at: <http://www.who.int/bulletin/volumes/93/08-/14-148056>). The attributable proportions -- i.e. the percentages of the cases of the sequelae that could be attributed to one of our pathogens of interest -- varied from 0.03%, for Guillain-Barré syndrome and *Campylobacter*, to 9.14%, for haemorrhagic colitis and EHEC.

###### Proportions of cases of sequelae attributable to *Campylobacter* spp., *Salmonella* sp. or enterohaemorrhagic *Escherichia coli*

  Pathogen, sequelae            Attributable proportion, % of cases of sequelae, (95% UI)   No. of studies   Country
  ----------------------------- ----------------------------------------------------------- ---------------- ---------------------------------------------------------------------------------------------
  ***Campylobacter* spp.**                                                                                   
  Guillain-Barré syndrome       0.03 (0.02--0.06)                                           3                Netherlands, Sweden
  Inflammatory bowel disease    0.30 (0.27--0.34)                                           2                Denmark, Sweden
  Reactive arthritis            5.01 (2.60--8.08)                                           14               Denmark, Finland, Netherlands, Norway, United Kingdom, USA
  ***Salmonella* sp.**                                                                                       
  Inflammatory bowel disease    0.43 (0.38--0.48)                                           2                Denmark, Sweden
  Reactive arthritis            6.09 (2.81--10.47)                                          12               Australia, Denmark, Finland, Netherlands, Switzerland, United Kingdom, USA
  **EHEC**                                                                                                   
  Haemorrhagic colitis          9.14 (4.17--15.51)                                          2                Germany, United Kingdom
  Haemolytic uraemic syndrome   6.13 (4.61--7.82)                                           23               Austria, Belgium, Canada, Denmark, Finland, Germany, Hungary, Slovakia, United Kingdom, USA

EHEC: enterohaemorrhagic *Escherichia coli*; UI: uncertainty interval; USA: United States of America.

Sources: Data drawn from the results of identified studies.[@R21]^--^[@R69]
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[Table 4](#T4){ref-type="table"} summarizes the numbers of deaths recorded in Japan in 2011 that were attributed to gastroenteritis caused by foodborne *Campylobacter*, *Salmonella* or EHEC or to the related complications. No deaths were attributed to gastroenteritis caused by *Campylobacter*, reactive arthritis or haemorrhagic colitis.

###### Burdens posed by foodborne diseases caused by *Campylobacter* spp., *Salmonella* sp. or enterohaemorrhagic *Escherichia coli*, Japan, 2011

  Causative agent, condition                Incidence, cases (95% UI)   Fatal cases   Years of illness   Disability weight   Burden metrics         YLD/DALY (%)                             
  ----------------------------------------- --------------------------- ------------- ------------------ ------------------- ---------------------- ---------------- ----------------------- -------
  ***Campylobacter* spp.**                                                                                                                                                                   
  Gastroenteritis                           118 502 (70 654--197 823)   --            --                 --                  122                    0                122                     
      Visiting a general practitioner       4 833 (3 439--7 156)        0             0.03               0.39                50 (42--66)            0                50 (42--66)             100.0
      Not visiting a general practitioner   114 219 (67 864--190 644)   0             0.01               0.07                72 (42--122)           0                72 (42--122)            100.0
  Mild Guillain-Barré syndrome              30 (14--60)                 0             1.00               0.25                7 (5--12)              0                7 (5--12)               100.0
  Severe Guillain-Barré syndrome            5 (3--11)                   1             29.26              0.16                29 (13--57)            12 (6--21)       42 (24--69)             69.0
  Reactive arthritis                        6 087 (2 956--11 156)       0             0.61               0.14                520 (257--952)         0                520 (257--952)          100.0
  Inflammatory bowel disease                452 (93--1 051)             4             44.36              0.26                5 261(1 095--12 393)   83 (31--150)     5 344 (1 173--12 475)   98.4
  Total                                     --                          --            --                 --                  6003 (1 651--13 687)   96 (42--160)     6 099 (1 745--13 778)   98.4
  ***Salmonella* sp.**                                                                                                                                                                       
  Gastroenteritis                           40 571 (24 607--66 382)     --            --                 --                  70                     122              192                     
      Visiting a general practitioner       3 866 (3 411--4 658)        3             0.03               0.39                47 (42--56)            122 (8--292)     169 (52--338)           27.8
      Not visiting a general practitioner   36 667 (21 237--62 597)     0             0.02               0.07                23 (13--37)            0                23 (13--37)             100.0
  Reactive arthritis                        2 556 (1 190--4 774)        0             0.61               0.15                227 (119--390)         0                227 (119--390)          100.0
  Inflammatory bowel disease                202 (36--481)               2             50.52              0.26                2652(492--6 211)       38 (13--69)      2 690 (522--6 236)      98.6
  Total                                     --                          --            --                 --                  2979 (753--6 795)      166 (49--350)    3 145 (906--6 950)      94.7
  **EHEC**                                                                                                                                                                                   
  Gastroenteritis                           103 338 (63 419--170 419)   --            --                 --                  75                     130              205                     
      Visiting a general practitioner       2 064 (1 955--2 175)        10            0.02               0.39                12 (11--13)            130 (53--232)    142 (65--244)           8.5
      Not visiting a general practitioner   101 982 (60 428--169 268)   0             0.01               0.07                63 (38--96)            0                63 (38--96)             100.0
  Haemorrhagic colitis                      229 (115--361)              0             0.02               0.39                1 (1--2)               0                1 (1--2)                100.0
  Haemolytic uraemic syndrome^a^            132 (108--155)              3             NA                 NA                  133 (109--159)         108 (42--196)    240 (169--326)          55.4
  Total                                     --                          --            --                 --                  211 (171--266)         252 (129--395)   463 (325--606)          45.6

DALY: disability-adjusted life-years; EHEC: enterohaemorrhagic *Escherichia coli*; NA: not available; UI: uncertainty interval; YLD: years lived with disability; YLL: years of life lost.

^a^ Every case was estimated to correspond to 1.05 years lived with disability.[@R17]

Sources: years of illness and disability weights were based on values provided by Van Lier and Havelaar[@R17] and Kemmeren et al.[@R18]

[Table 4](#T4){ref-type="table"} also presents disability weights, disease durations, estimated incidences and disease burdens in terms of DALYs. Most of the overall disease burden posed by foodborne *Campylobacter*, *Salmonella* or EHEC was the result of a relatively small number of complications.

Discussion
==========

Our study provides national estimates of incidence, deaths and disease burden in DALYs, caused by *Campylobacter*, *Salmonella* and EHEC in Japan in 2011.

Estimates of annual incidence were approximately 92.5, 31.7 and 80.7 cases per 100 000 population for gastroenteritis caused by foodborne *Campylobacter*, *Salmonella* and EHEC, respectively. These estimates were many-fold higher than the values indicated by the results of routine surveillance, which ranged from 0.6 to 2.4 cases per 100 000 population. In 2011 at least, Japan's routine surveillance system for foodborne diseases appeared to grossly underreport the incidence of acute gastroenteritis caused by our pathogens of interest. One probable cause of such underreporting is that the surveillance system focuses on clusters, outbreaks and other large public health events and usually ignores individual sporadic cases.[@R73]

Our estimate of the annual incidence of gastroenteritis caused by foodborne *Campylobacter* appears relatively low for a high-income country. Previous estimates of such incidence in a high-income country have ranged from 440 per 100 000, in the United States in 2006, to 930 per 100 000, in the United Kingdom in 2008--2009.[@R74] Apparent geographical variation in the incidence of such disease may partly reflect between-country and between-study differences in the surveillance methods employed. In some countries, population-based cohort studies -- e.g. the Sensor study in the Netherlands and two Infectious Intestinal Disease studies in the United Kingdom[@R75]^--^[@R77] -- are being used. In Australia, Canada and the United States, a surveillance pyramid method that included information on hospital visits and laboratory-confirmed cases is being employed.[@R78]^--^[@R82] Harmonization of methods will be necessary if we are to make meaningful comparisons of incidence estimates between countries and over time. The results of this pilot study will hopefully help FERG to improve its recommendations and the production of comparable, consistent estimates of the incidences of foodborne diseases.

In our study, to address the potential bias resulting from the one-day hospital reporting period and the inclusion only of laboratory-confirmed cases, we applied a pyramid reconstruction technique similar to that used in previous research.[@R78]^--^[@R82] Although this technique allows some adjustment for seasonality, care-seeking and diagnostic factors, it has several limitations. First, we estimated the age-specific incidence of gastroenteritis based on food poisoning statistics from a passive surveillance system, that tends to miss sporadically occurring cases.[@R83] To make the estimation of the number of cases occurring annually in each age group more accurate, active surveillance -- via national surveys or a population-based surveillance network -- would be needed.

Second, we restricted the sequelae we investigated to those previously identified in a European study. In Japan, there may be different or more complications than observed in Europe.

Third, we based some of our estimation process on a systematic review of sequelae from other countries, where the epidemiology of foodborne disease may differ from that in Japan -- e.g. because of the geographical variation in dietary habits.

Fourth, the validity and comparability of the disability weights that we used may be limited. In the field of foodborne disease, information on disability weights for specific complications is scarce. Hopefully, relevant data will soon be provided by FERG.[@R72]

Finally, our estimates of the proportion of gastroenteritis resulting from foodborne transmission were based on expert opinion instead of empirical data. The size of the so-called foodborne fraction appears to vary markedly depending on the country involved. Such a large variation may be due to differences in dietary habit, consumer tastes, food processing and food safety -- but may also reflect differences in the methods used to investigate transmission pathways.

The approach recommended by FERG appears useful for understanding the magnitude of foodborne diseases, prioritizing food safety interventions and policies and harmonizing methods for the estimation of the foodborne disease burden.
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